Oxford Asset Management’s Organogenesis Holdings ORGO Stock Holding History

Oxford Asset Management’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-37,842	Closed	-$89.7K	–	550
2026 Q1	$89.7K	Buy	37,842 +25,190	+199%	+$87.3K	0.04%	430
2025 Q4	$65.5K	Buy	+12,652	New	+$61.3K	0.02%	472
2024 Q2	–	Sell	-22,631	Closed	-$64.3K	–	386
2024 Q1	$64.3K	Buy	+22,631	New	+$76.9K	0.07%	242
2018 Q4	–	Sell	-1,538,000	Closed	-$15.6M	–	1996
2018 Q3	$15.6M	Buy	1,538,000 +538,000	+54%	+$5.43M	0.33%	29
2018 Q2	$10M	Buy	+1,000,000	New	+$10M	0.19%	96

Other funds holding ORGO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Oxford Asset Management's ORGO Position: Q2 2026 in Review

Oxford Asset Management sold out of Organogenesis Holdings (ORGO) in Q2 2026, closing a stake of 37,842 shares — an estimated $89.7K sold.

Oxford Asset Management first reported a position in ORGO in Q2 2018 and held it in 5 quarters. The position peaked at $15.6M in Q3 2018. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

Oxford Asset Management reported no remaining Organogenesis Holdings position as of Q2 2026 after selling out during the quarter.
Oxford Asset Management sold 37,842 Organogenesis Holdings shares in Q2 2026, an estimated $89.7K.
Oxford Asset Management first reported a position in Organogenesis Holdings in Q2 2018 and held it in 5 quarters.
Oxford Asset Management's Organogenesis Holdings position peaked at $15.6M in Q3 2018.
136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Oxford Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.